Abiopharma

QUADIENT SA (ADNT) Reports the reporting period Financial Results QUADIENT SA (ADNT) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: Not disclosed
• Net Income: Not disclosed
• EPS: Not disclosed
• Cash and equivalents: $55
  • Targeting self-help actions to increase production flexibility Investing to support current and future operational capabilities Laser-focused on growth – Strategically growing new business New program launches driving growth over market in core business New business wins support revenue durability Disciplined portfolio optimization i.e. third-party metals business rolls off 5 Adient – PUBLIC Q&A Adient – PUBLIC Appendix and Financial Reconciliations FY26 Third Quarter Adient – PUBLIC August 13, 2026